NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 52 filers reported holding NOVELION THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,759,000 | +2.8% | 3,909,207 | +5.6% | 1.92% | -26.2% |
| Q3 2019 | $2,685,000 | +601.0% | 3,703,420 | +654.1% | 2.61% | +887.1% |
| Q2 2019 | $383,000 | -14.3% | 491,096 | -7.6% | 0.26% | -32.8% |
| Q4 2018 | $447,000 | -91.3% | 531,662 | -69.2% | 0.39% | -86.9% |
| Q3 2018 | $5,118,000 | -22.4% | 1,728,887 | -3.6% | 2.99% | -25.3% |
| Q2 2018 | $6,598,000 | +1.4% | 1,792,911 | -3.6% | 4.01% | +14.9% |
| Q1 2018 | $6,510,000 | +23.1% | 1,860,000 | +9.8% | 3.49% | +10.1% |
| Q4 2017 | $5,288,000 | -58.8% | 1,694,717 | -7.2% | 3.17% | -58.1% |
| Q3 2017 | $12,839,000 | -24.9% | 1,826,364 | -1.4% | 7.57% | -18.0% |
| Q2 2017 | $17,098,000 | +2.0% | 1,852,395 | +18.7% | 9.23% | -2.2% |
| Q1 2017 | $16,760,000 | +30.6% | 1,560,487 | +2.4% | 9.44% | +23.6% |
| Q4 2016 | $12,832,000 | – | 1,524,034 | – | 7.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|